Imperial Enterprise – September Newsletter 

Stay in the know on our healthcare innovations

Nothing motivates Imperial researchers more than tackling health challenges and improving lives, as you will see from several of our recent developments. Gene therapy spinout AlveoGene has formed to offer a solution, decades in development, to the major challenge of how to effectively deliver therapeutic genes into the body for the treatment of rare lung conditions. SPARTA Biodiscovery, a one-year-old spinout that is helping pharmaceutical companies create nanoparticle medicines that deliver active agents exactly where they’re needed in the body, has made excellent progress. And we’ve begun working with US company MediBeacon to develop a non-invasive method for assessing gut health using fluorescent dyes.

We’ve also redoubled our efforts to make it easy for prospective commercial partners to learn about opportunities to collaborate on Imperial technologies. We were delighted last week to be inundated with meeting requests at our buzzy IP4U technology fair, which showcased health and sustainability technologies from Imperial, Cambridge, Oxford and UCL to 500 industry attendees over two days of demos and discussion in South Kensington. London Demo Day, which showcased student startups from Imperial, Kings, LSE and UCL, was packed to capacity. And to meet this intense demand for information about our startups, our President Hugh Brady, in San Francisco with another delegation of Imperial healthcare startups, last week announced the launch of an online portal for professional investors. To request access, email Dr James Groves, our Head of Investment Services.

Next on our agenda is BioJapan 2023, Asia’s top biotech partnering event, which takes place in October in Yokohama. If you’re attending, look out for keynote speeches by Professor Brady and Professor Graham Cooke, Vice Dean (Research) in Medicine, and the large Imperial delegation who’ll be available for in-person conversations. Closer to home this November we are running Connect, Collaborate, Innovate in London which will help organisations submit successful Innovate UK bids with Imperial.

As ever, to start a one-to-one conversation you can also drop us a line using our contact form, and if you have colleagues who would also benefit from regular updates from us they can join our mailing list here.

Best wishes,

Dr Simon Hepworth

Director of Enterprise

Imperial College London

News

Gene genius

A new spinout, AlveoGene, will develop gene therapies for several rare lung conditions. The company was co-founded Professors Uta Griesenbach and Eric Alto, pictured above.

Flawless AI joins I-X

US tech startup Flawless AI has joined I-X, Imperial’s new home for AI research, as an early member of its business partner programme. The partnership will help advance the use of AI in the entertainment and creative sectors.

$226m for medicine translation

Apollo Therapeutics, a company founded by the tech transfer offices of Imperial, Cambridge and UCL, has raised major Series C funding to turn basic university research into medicines.

IBP impact report (PDF)

A new report from Imperial Business Partners explores the impact that joining Imperial's corporate membership programme has had on several global businesses.

Gut health tech

Imperial and US medical technology company MediBeacon have partnered to advance a non-invasive method of assessing intestinal health using fluorescent dye.

Investment portal

A new online portal will help investors discover Imperial's startups.

London Demo Day

Five startups from Imperial College London pitched their early-stage ideas to leading investors at King’s College London at the fourth annual London Demo Day. 

Startups showcased in San Francisco

Five Imperial startups have travelled to San Francisco to showcase technologies that will allow people to take ownership of their health and wellbeing.

Events

BioJapan 2023

11-13 Oct, Yokohama, Japan

Imperial's President Hugh Brady, and Professor Graham Cooke, Vice Dean (Research) in the Faculty of Medicine, will deliver keynotes at Asia's premier biotech partnering event.

Connect, Collaborate, Innovate 2023 

1 Nov, White City

Connect with leading academics in Innovate UK’s three innovation domains: net zero, healthy living, digital and technologies, and set your organisation up for successful Innovate UK bids.

Connect with us 

Contact us | Our website | Twitter | LinkedIn | Subscribe  

You have received this email because you subscribed to the Enterprise Newsletter or agreed to receive communications from Imperial Enterprise.

This email was sent from enterprise@imperial.ac.uk

Copyright © 2023 Imperial College London, All rights reserved.